Results

Edgewise Therapeutics Inc.

10/28/2021 | Press release | Distributed by Public on 10/28/2021 04:11

Edgewise Therapeutics Announces Positive Topline Results from the EDG-5506 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HVs) and Doses First Becker[...]